Evolent Health, Inc. (EVH)
USD 10.71
(-1.47%)
USD 10.71
(-1.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 142.58 Million | -11.55 Million | 38.74 Million | -16.22 Million | -42.64 Million | -20.65 Million |
| Net Income | -113.04 Million | -19.16 Million | -37.6 Million | -334.24 Million | -305.58 Million | -54.19 Million |
| Depreciation & Amortization | 123.41 Million | 67.19 Million | 60.03 Million | 61.47 Million | 60.91 Million | 44.51 Million |
| Deferred income taxes | -31.27 Million | 342 Thousand | -526 Thousand | -1.13 Million | -23.12 Million | 44 Thousand |
| Stock-based compensation | 40.5 Million | 33.98 Million | 16.71 Million | 14.6 Million | 15.61 Million | 17.6 Million |
| Change in working capital | 21.89 Million | -104.44 Million | -13.64 Million | -55.31 Million | 331 Thousand | -34.86 Million |
| Other non-cash items | 101.08 Million | 10.53 Million | 13.77 Million | 298.39 Million | 209.19 Million | 6.23 Million |
| Investing Cash Flow | -415.54 Million | -259.11 Million | -15.78 Million | 261.07 Million | -181.63 Million | -160.37 Million |
| Investments in PPE | -28.74 Million | -38.36 Million | -24.98 Million | -29.47 Million | -35.53 Million | -39.55 Million |
| Acquisitions | 870 Thousand | 5.55 Million | -34.79 Million | -300 Thousand | -96.05 Million | -139.6 Million |
| Investment purchases | -870 Thousand | -5.55 Million | -2.99 Million | -11.17 Million | -11.12 Million | -10.01 Million |
| Sales/Maturities of investments | 870 Thousand | 5.55 Million | 500 Thousand | 143.44 Million | 2.57 Million | 349 Thousand |
| Other Investing Activities | -387.66 Million | -226.3 Million | 46.48 Million | 158.57 Million | -41.49 Million | 28.43 Million |
| Financing Cash Flow | 281.34 Million | 131.54 Million | -29.54 Million | -11.86 Million | -35.54 Million | 274.02 Million |
| Debt repayment | -183.29 Million | -219.74 Million | -98.84 Million | -16.6 Million | -62.64 Million | -167.17 Million |
| Dividends payments | -18.79 Million | -14.88 Million | -1.3 Million | -20 Million | - | - |
| Common Stock Repurchased | -15.29 Million | -18.31 Million | -3.85 Million | -1.85 Million | -2.6 Million | -1.23 Million |
| Common Stock Issuance | 180.51 Million | 4.45 Million | 13.28 Million | 2.57 Million | 1.09 Million | 11.92 Million |
| Other Financing Activities | -63.67 Million | 380.03 Million | 61.16 Million | 24.01 Million | 89.75 Million | 274.02 Million |
| Accounts receivables | -164.69 Million | -102.98 Million | -5.77 Million | -47.01 Million | 6.32 Million | -24.5 Million |
| Accounts payables | -6.72 Million | 13.16 Million | 7.25 Million | 3.54 Million | -5.48 Million | 7.59 Million |
| Inventory | -10.74 Million | - | -14.11 Million | 47.01 Million | -19.5 Million | 644 Thousand |
| Other working capital | 204.05 Million | -14.62 Million | -1 Million | -58.86 Million | 18.98 Million | -18.6 Million |
| Cash at beginning of period | 215.15 Million | 354.94 Million | 361.58 Million | 128.53 Million | 388.32 Million | 295.36 Million |
| Cash at end of period | 223.45 Million | 215.15 Million | 354.94 Million | 361.58 Million | 128.53 Million | 388.32 Million |
| Capital Expenditure | -28.74 Million | -38.36 Million | -24.98 Million | -29.47 Million | -35.53 Million | -39.55 Million |
| Effect of forex changes on cash | -79 Thousand | -657 Thousand | -52 Thousand | 65 Thousand | 30 Thousand | -36 Thousand |
| Net cash flow / Change in cash | 8.29 Million | -139.78 Million | -6.63 Million | 233.05 Million | -259.79 Million | 92.96 Million |
| Free Cash Flow | 113.83 Million | -49.91 Million | 13.76 Million | -45.69 Million | -78.17 Million | -60.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.59 Million | -17.28 Million | -33.41 Million | -113.04 Million | -25.32 Million | -34.32 Million |
| Depreciation & Amortization | 30.98 Million | 29.5 Million | 29.6 Million | 123.41 Million | 32.4 Million | 32.13 Million |
| Deferred income taxes | -1.16 Million | 181 Thousand | -19.26 Million | -31.27 Million | -7.17 Million | -2.29 Million |
| Stock-based compensation | 12.65 Million | 18.78 Million | 10.6 Million | 40.5 Million | 10.22 Million | 8.96 Million |
| Change in working capital | -25.99 Million | -38.34 Million | 49.2 Million | 21.89 Million | 34.94 Million | -22.62 Million |
| Other non-cash items | 30.86 Million | 79.26 Million | 52.64 Million | 101.08 Million | 15.45 Million | 18.79 Million |
| Investing Cash Flow | -13.54 Million | -9.73 Million | -6.05 Million | -415.54 Million | -6.14 Million | -8.35 Million |
| Investments in PPE | -7.1 Million | -5.34 Million | -6.05 Million | -28.74 Million | -6.79 Million | -6.84 Million |
| Acquisitions | -4.56 Million | -1.38 Million | - | 870 Thousand | - | -1.52 Million |
| Investment purchases | -1.88 Million | -3 Million | - | -870 Thousand | - | 1.5 Million |
| Sales/Maturities of investments | 7000.00 | - | - | 870 Thousand | 71 Thousand | 13 Thousand |
| Other Investing Activities | -4.56 Million | -1.38 Million | -870 Thousand | -387.66 Million | 577 Thousand | -1.5 Million |
| Financing Cash Flow | -103.38 Million | 14.88 Million | -84.35 Million | 281.34 Million | -37.36 Million | 23.33 Million |
| Debt repayment | - | -529 Thousand | -25.27 Million | -183.29 Million | -10 Million | -267 Thousand |
| Dividends payments | -5.06 Million | -5.07 Million | -5.16 Million | -18.79 Million | -5.09 Million | -4.88 Million |
| Common Stock Repurchased | -364 Thousand | -14.33 Million | -944 Thousand | -15.29 Million | -1.6 Million | -138 Thousand |
| Common Stock Issuance | 61 Thousand | 1.05 Million | 3.33 Million | 180.51 Million | 4.52 Million | 3.07 Million |
| Other Financing Activities | -98.37 Million | 19.43 Million | -57.25 Million | -63.67 Million | -26.8 Million | 25.4 Million |
| Accounts receivables | 54.01 Million | 19 Million | -52.51 Million | -164.69 Million | -49.04 Million | -82.96 Million |
| Accounts payables | -6.9 Million | -8.42 Million | 5.9 Million | -6.72 Million | 104 Thousand | 853 Thousand |
| Inventory | - | - | -39.59 Million | -10.74 Million | 7.63 Million | 31.96 Million |
| Other working capital | -73.1 Million | -48.93 Million | 135.41 Million | 204.05 Million | 76.24 Million | 27.52 Million |
| Cash at beginning of period | 216.74 Million | 206.59 Million | 224.49 Million | 215.15 Million | 207.59 Million | 191.97 Million |
| Cash at end of period | 121.3 Million | 216.74 Million | 223.45 Million | 223.45 Million | 224.49 Million | 207.59 Million |
| Capital Expenditure | -7.1 Million | -5.34 Million | -6.05 Million | -28.74 Million | -6.79 Million | -6.84 Million |
| Effect of forex changes on cash | -24 Thousand | -38 Thousand | -18 Thousand | -79 Thousand | -110 Thousand | -1000.00 |
| Net cash flow / Change in cash | -95.43 Million | 10.14 Million | -1.04 Million | 8.29 Million | 16.89 Million | 15.62 Million |
| Free Cash Flow | 14.31 Million | -438 Thousand | 83.32 Million | 113.83 Million | 53.72 Million | -6.19 Million |
BOMDYEING
1931
QPM
LWAY
GVC
TLGRF